Genetically determined recurrent fevers

Area of Science:

• Genetics
• Molecular Biology
• Immunology

Background:

• Genetic mutations in MEFV are linked to familial Mediterranean fever (FMF) severity and renal amyloidosis.
• The serum amyloid-associated protein (SAA)1 alpha/alpha allele acts as a modifier for amyloidosis in FMF patients.
• TNF-receptor-associated periodic syndrome (TRAPS) appears more common following the identification of its causative gene.

Purpose of the Study:

• To explore the genetic underpinnings of recurrent fevers, focusing on MEFV mutations in FMF.
• To investigate the role of SAA1 alleles in modifying amyloidosis risk in FMF.
• To assess the prevalence and genetic characteristics of TNF-receptor-associated periodic syndrome (TRAPS).

Main Methods:

• Analysis of MEFV gene mutations in patients with familial Mediterranean fever.
• Genotyping for the serum amyloid-associated protein (SAA)1 alpha/alpha allele.
• Comparative genetic studies across species to understand mutation origins.
• Review of clinical data for TNF-receptor-associated periodic syndrome cases.

Main Results:

• MEFV mutations correlate with FMF severity and amyloidosis risk.
• The SAA1 alpha/alpha genotype is identified as a significant modifying factor for amyloidosis.
• Human MEFV mutations reflect ancestral states, with key domains absent in rodent models.
• New mutations in the TRAPS-associated gene suggest increased frequency and incomplete penetrance in some cases.

Conclusions:

• Molecular diagnostics are essential for managing genetically determined recurrent fevers.
• Understanding genetic factors like MEFV mutations and SAA1 alleles improves FMF patient outcomes.
• Further research into TRAPS genetics is warranted due to observed incomplete penetrance.